 Home > Medical News > Latest Medical News > Compete with HAE's first oral therapeutic drug!

Compete with HAE's first oral therapeutic drug!

 Last Update: 2021-08-29
 Source: Internet
 Author: User

Tags

long chlorine rash

dialysis drugs 2018

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Recently, BioCryst launched Orladeyo, the first oral treatment for hereditary angioedema (HAE), and the North Carolina-based biotechnology company has priced Orladeyo lower than its main competitors, Takeda and CSL Behring

A few days ago, Takeda launched a "counterattack.

The first analysis of the results of the Takhzyro study showed that compared with baseline, patients treated with Takhzyro reduced angioedema episodes by an average of 87.

Hereditary angioedema is a rare lifelong disease that can cause rapid swelling of the patient’s hands, feet, limbs, face, intestines, or respiratory tract

However, with the advent of Orladeyo, which is more affordable and more convenient to take, the situation in the hereditary angioedema market may change rapidly

In December 2020, BioCryst announced that it has been approved by the US FDA to prevent the onset of hereditary angioedema (HAE) in children and adults 12 years of age and older.

Between October and December 2020, Takeda reported that Takhzyro’s quarterly sales reached $210 million

Reference source: With Takhzyro durability data, Takeda tries to fend off BioCryst's hereditary angioedema challenger Orladeyo

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.